Clinical and epidemiological profile of patients diagnosed with neurocysticercosis at two hospitals in Chiclayo, Peru
DOI:
https://doi.org/10.24265/horizmed.2017.v17n1.03Keywords:
Neurocysticercosis, Epidemiology, Taenia solium, PeruAbstract
Objective: To describe the clinical and epidemiological profile of patients diagnosed with neurocysticercosis at two hospitals in Chiclayo, Peru.
Materials and methods: A descriptive, cross-sectional and retrospective study was performed at the Almanzor Aguinaga Asenjo Hospital and Lambayeque Regional Hospital. Ninety-six (96) medical records of patients attended in 2014 with a diagnosis of neurocysticercosis were reviewed.
Results: The mean age of the patients was 42.8 ± 18.8 years old, 52.1% were female, 26% came from Chiclayo and 54.2% received care for the first time. The most common symptom leading to medical consultation was headache. All patients underwent a diagnostic imaging method. The location of the parasite was mostly in the brain and the calcified stage was the most common one. The most widely used treatments were anticonvulsants and pain relievers.
Conclusions: Neurocysticercosis mainly affects the economically active population, is more common in women and the most common clinical manifestation is headache.
Downloads
References
Garcia HH, Gonzalez AE, Rodriguez S, Gonzalvez G, LlanosZavalaga F, Tsang VC, et al. Epidemiology and control of cysticercosis in Peru. Rev Peru Med Exp Salud Publica. 2010;27(4):592–7.
Escalante H, Pereda F, Sánchez M, Schulz H, Torres P, Davelois K. Pacientes neurológicos Del noroeste Del Perú con serología positiva por western blot a la larva de Taenia solium. Rev Peru Med Exp Salud Publica. 2004;21(2):92–7.
Cysticercosis Working Group in Peru. The marketing of cysticercotic pigs in the Sierra of Peru. The Cysticercosis Working Group in Peru. Bull World Health Organ. 1993;71(2):223–8.
Ministerio de Salud. Teniasis / cisticercosis por taenia solium un serio problema de Salud Pública en el Perú [Internet]; 2001 [Citado el 12 de abril de 2015]. Disponible en: http://www.dge.gob.pe/publicaciones/pub_invepi/iepi0.pdf
Murrell KD. WHO/FAO/OIE Guidelines for the surveillance, prevention and control of taeniosis/cysticercosis. Paris: OIE; 2005. 1–139. Disponible en: http://www.oie.int/doc/ged/d11245.pdf
Del Brutto O. Neurocisticercosis: actualización en diagnóstico y tratamiento. Neurologia. 2005;20(8):412–8.
Sinha S, Sharma BS. Neurocysticercosis: a review of current status and management. J Clin Neurosci Off J Neurosurg Soc Australas. 2009;16(7):867–76.
Esquicha JA, Falcón N, Oshiro S. Características clínicas y epidemiológicas de los pacientes con neurocisticercosis en un hospital general de Lima. Rev Medica Hered. 2012;23(1):4–10.
Fleury A, Dessein A, Preux PM, Dumas M, Tapia G, Larralde C, et al. Symptomatic human neurocysticercosis--age, sex and exposure factors relating with disease heterogeneity. J Neurol. 2004;251(7):830–7.
Fleury A, Escobar A, Fragoso G, Sciutto E, Larralde C. Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors. Trans R Soc Trop Med Hyg. 2010;104(4):243–50.
Garcia HH, Gilman RH, Gonzalez AE, Pacheco R, Verastegui M, Tsang VCW. Human and porcine Taenia solium infection in a village in the highlands of Cusco, Peru. Acta Trop. 1999;73(1):31–6.
Rajkotia Y, Lescano AG, Gilman RH, Cornejo C, Garcia HH, Cysticercosis Working Group of Peru. Economic burden of neurocysticercosis: results from Peru. Trans R Soc Trop Med Hyg. 2007;101(8):840–6.
Carpio A. Clinical Diagnoses of Neurocysticercosis. En: Foyaca Sibat H, editor. Novel Aspects on Cysticercosis and Neurocysticercosis [Internet]. InTech; 2013 [citado el 12 de octubre de 2015]. Disponible en: http://www.intechopen.com/books/novel-aspects-on-cysticercosis-andneurocysticercosis/clinical-diagnoses-of-neurocysticercosis
Escalante C, Escalante G. Neurocisticercosis en el niño. Análisis epidemiológico y clínico. Rev Neuropsiquiatr. 2013;68(3-4):201–11.
Kimura-Hayama ET, Higuera JA, Corona-Cedillo R, Chávez-Macías L, Perochena A, Quiroz-Rojas LY, et al. Neurocysticercosis: radiologic-pathologic correlation. Radiogr Rev Publ Radiol Soc N Am Inc. 2010;30(6):1705–19.
Saavedra H, Gonzales I, Alvarado MA, Porras MA, Vargas V, Cjuno RA, et al. Diagnóstico y manejo de la neurocisticercosis en el Perú. Rev Peru Med Exp Salud Pública. 2010;27(4):586– 91.
Del Brutto O, Garcia HH. Clinical Manifestations of Neurocysticercosis. En: Cysticercosis of the Human Nervous System. 1a ed. Berlin: Springer; 2014.
Del Brutto O, Garcia HH. Neuropathology of Cysticercosis. En: Cysticercosis of the Human Nervous System. 1a ed. Berlin: Springer; 2014.
Valenzuela-Borrayo LC. Neurocisticercosis en México, revisión de la literatura. Hipoc Rev Med. 2010;23:4-8.
The center for food security and public health. Taenia infections. Tech Factsheets [Internet]; 2005. Disponible en: http://www.cfsph.iastate.edu/Factsheets/pdfs/taenia.pdf
Del Brutto O, Garcia HH. Inmunopathology of Taeniasis and Cysticercosis. En: Cysticercosis of the Human Nervous System. 1a ed. Berlin: Springer; 2014.
Del Brutto O, Garcia HH. Epidemiology of Human Cysticercosis in Endemic Regions. En: Cysticercosis of the Human Nervous System. 1a ed. Berlin: Springer; 2014.
Del Brutto O, Garcia HH. Diagnosis of Taeniasis and Cysticercosis. En: Cysticercosis of the Human Nervous System. 1a ed. Berlin: Springer; 2014.
Del Brutto O, Garcia HH. Management of Neurocysticercosis. En: Cysticercosis of the Human Nervous System. 1a ed. Berlin: Springer; 2014.
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
